Join the DDA or

Former Lexon director disqualified for illegal acts

Anti-competitive practices result in four-year director ban

January 13th 2022

Tagged: DM Zone news

By Ailsa Colquhoun

Former Lexon director Pritesh Sonpal has been disqualified by the Competition and Markets Authority in connection with his involvement in illegal anti-competitive practices. 

Sonpal has been disqualified from taking up any director role or being involved in the management of any company based in England, Scotland or Wales for four years, beginning on Wednesday 12 January. 

This move follows the Competition and Markets Authority’s (CMA) decision in March 2020, which found that wholesaler Lexon – along with the pharmaceutical companies King Pharmaceuticals and Alissa Healthcare Research – illegally shared commercially sensitive information on prices, supply volumes and market activity about the antidepressant nortriptyline. As a result, Lexon was fined £1.2 million for breaking competition law. 

Lexon subsequently appealed against the CMA’s decision, but the decision was upheld in full in February 2021 by the Competition Appeal Tribunal (CAT).  

Sonpal has accepted the CAT’s findings that his actions caused Lexon to participate in the illegal exchange of sensitive commercial information.